10-Q: Blue Biofuels Reports Q2 2024 Results, Focuses on Commercialization and SAF Production

Blue Biofuels reported its second quarter 2024 financial results, highlighting ongoing efforts in technology development and strategic partnerships for sustainable aviation fuel production.

Summary

• Blue Biofuels, Inc. reported no revenue for the three and six months ended June 30, 2024, consistent with the same periods in 2023.
• The company's net loss for the six months ended June 30, 2024, was $1,495,695, compared to a net loss of $2,218,288 for the same period in 2023.
• General and administrative expenses decreased to $545,736 for the six months ended June 30, 2024, from $725,169 in 2023, primarily due to lower stock-based compensation and professional fees.
• Research and development expenses decreased to $899,025 for the six months ended June 30, 2024, from $1,447,276 in 2023, mainly due to reduced bonuses and equity-based compensation.
• The company's total assets were $1,305,453 as of June 30, 2024, compared to $1,030,219 at the end of 2023.
• Total liabilities increased to $6,058,006 as of June 30, 2024, from $4,591,301 at the end of 2023, primarily due to new convertible notes and deferred wages.
• The company has a working capital deficit of $1,549,579 as of June 30, 2024, and accumulated losses of $57,332,475 since inception.
• Blue Biofuels is focused on commercializing its Cellulose-to-Sugar (CTS) technology and developing a sustainable aviation fuel (SAF) facility through a joint venture with Vertimass.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While there are positive developments such as the joint venture and patent grants, the company's lack of revenue, significant losses, and dependence on future capital raises create a negative sentiment. The company is still in the early stages of commercialization and faces significant financial challenges.

Positives

• The company's net loss decreased compared to the same period last year, indicating improved cost management.
• The formation of the VertiBlue Fuels joint venture is a significant step towards commercializing SAF production.
• The company's patented CTS technology has received international recognition with patents granted in multiple countries.
• The company has secured a license for the Vertimass Process, which is crucial for SAF production.
• The company is actively pursuing government incentives and credits for renewable fuel production.
• The company has increased its cash position from $41,008 at the end of 2023 to $407,806 as of June 30, 2024.

Negatives

• The company has not generated any revenue to date.
• The company has a significant working capital deficit of $1,549,579.
• The company has accumulated losses of $57,332,475 since inception.
• The company's total liabilities have increased to $6,058,006.
• The company is dependent on raising additional capital to continue operations.
• The company's ability to continue as a going concern is uncertain.

Risks

• The company's ability to continue as a going concern is dependent on obtaining additional financing and generating revenue.
• The company faces risks related to the commercialization of its technology and the construction of its SAF facility.
• The company is subject to regulatory risks and the need for government approvals for its operations.
• The company operates in a competitive industry with established players.
• The company's profitability is dependent on the price of feedstocks and the value of renewable fuel credits.
• The company's debt includes convertible notes that could dilute existing shareholders if converted.

Future Outlook

The company plans to commercialize its CTS technology and build a SAF facility, aiming for an initial production of 10 million gallons of SAF and expanding to 70 million gallons per year. The company anticipates raising the necessary capital for these projects and applying for various government incentives and credits.

Management Comments

• Management believes that the company's future success is dependent upon its ability to achieve profitable operations, generate cash from operating activities, and obtain additional financing.
• Management expects to be able to earn substantial renewable fuel credits and produce sustainable ethanol, sustainable aviation fuel, and other sustainable biofuels more profitably than existing commercial corn ethanol producers.
• Management believes that its management and consultants have significant experience in the development of technologies from concept to commercialization.

Industry Context

The company operates in the renewable energy and biofuels industry, which is characterized by increasing demand for sustainable alternatives to fossil fuels. The company's focus on cellulosic biofuels and SAF aligns with the industry's shift towards advanced biofuels and government mandates for renewable fuel blending. The company's technology aims to address the limitations of corn-based ethanol by utilizing a wider range of feedstocks and achieving higher yields.

Comparison to Industry Standards

• Blue Biofuels is developing cellulosic ethanol technology, which is a more advanced approach than traditional corn ethanol production, aligning with the industry's move towards more sustainable feedstocks.
• The company's partnership with K.R. Komarek for manufacturing its CTS machines is similar to other biofuel companies that partner with established engineering firms for scaling up production.
• The company's focus on sustainable aviation fuel (SAF) production is in line with the growing demand for low-carbon aviation fuels, a trend seen across the industry.
• The company's plan to leverage government incentives like D3 RINs, Clean Fuel Production Credits, and Low Carbon Fuel Standard Credits is a common practice among renewable fuel companies.
• Compared to companies like Gevo and Neste, which are also focused on SAF, Blue Biofuels is at an earlier stage of commercialization, with a focus on developing its core technology and securing project financing.

Related Party Transactions

• The company has short-term notes payable, convertible notes, and legacy liabilities issued to related parties.
• A board resolution was passed on February 13, 2020, that pledged the patents and pending patents to secure the back pay claims of Ben Slager, CEO, Anthony Santelli, CFO, and Charles Sills, Director.
• During the six-month period ended June 30, 2024, the board approved an increase in salaries to two officers of the Company retroactive to August 1, 2023.
• In June 2024, the board approved a partial anti-dilution compensation for CEO Ben Slager, CFO Anthony Santelli, and Director Chris Kneppers, to be paid in restricted stock units and options.
• As of 4/1/2024, interest is no longer accruing on back pay and directors fees. In lieu of interest, the Company will pay an additional $ 25,000 to each director contingent upon the financing of the first plant or the successful uplisting to the NYSE or Nasdaq.

Stakeholder Impact

• Shareholders face the risk of dilution from convertible notes and potential future equity raises.
• Employees may be impacted by the company's financial instability and dependence on future funding.
• Customers and suppliers are not directly impacted at this stage, as the company is still in the development phase.
• Creditors face the risk of non-payment due to the company's financial challenges.

Next Steps

• The company plans to commercialize its CTS technology.
• The company plans to build a commercial ethanol to SAF facility.
• The company plans to raise the necessary capital for these projects.
• The company plans to apply for various government incentives and credits.

Key Dates

Keywords

biofuels, renewable energy, sustainable aviation fuel, cellulosic ethanol, CTS technology, Vertimass, joint venture, D3 RIN, SAF, capital raise